Header Logo

Connection

MEGHANA TRIVEDI to Cyclin-Dependent Kinase 4

Back to Details
This is a "connection" page, showing publications MEGHANA TRIVEDI has written about Cyclin-Dependent Kinase 4.
MEGHANA TRIVEDI
Connection Strength
0.213
Cyclin-Dependent Kinase 4
  1. Cost Effectiveness of CDK4/6 Inhibitors in the First-Line Treatment of HR+/HER2- Metastatic Breast Cancer in Postmenopausal Women in the USA. Pharmacoeconomics. 2023 06; 41(6):709-718.
    View in: PubMed
    Score: 0.213
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.